A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma
about
Uveal melanoma: From diagnosis to treatment and the science in between.Management of uveal melanoma: a consensus-based provincial clinical practice guidelineIpilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.Current and emerging treatment options for uveal melanoma.Therapeutic opportunities in noncutaneous melanomaBiology of advanced uveal melanoma and next steps for clinical therapeutics.Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastasesCisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.Systemic treatment of metastatic uveal melanoma: review of literature and future perspectivesThe role of Bax and Bcl-2 in gemcitabine-mediated cytotoxicity in uveal melanoma cells.Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.Treatment of uveal melanoma: where are we now?The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors.Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
P2860
Q30251762-E6B50673-43AB-4A8E-80AB-38D3423AEAF9Q30388575-19392355-4F17-440B-8F19-F8B237811533Q33396664-3E2CAC1E-F31A-4564-94D5-4925DFB50CCDQ33413244-EBA80C03-FC0D-4041-9CC7-FF965F28BDEBQ34655878-B8B6793E-BD73-4076-8BE6-49A8717F462EQ35076179-4D55D711-4C10-4A39-AD84-89A8AF4265ADQ35079709-D07E8E1F-2488-4A33-B3D1-5E7F82150CCEQ35563368-752AA318-6688-4B2A-8406-9D27D2CB1350Q36610620-970212A9-BE64-4981-B5CB-851A1150A702Q37412316-BA3F12D0-7933-4DCC-8D80-10E403083325Q37482566-2F2D065A-69E4-43F3-8700-6F1A34CC57EBQ39098583-BF5E7572-7A01-4C92-8290-20F8AE79C334Q46230421-D9A73FBC-5951-46BB-81DD-F5FEC0A9FB6AQ50349181-72A4936C-BBA3-4F59-B191-CF08A1C1525FQ52671305-F4BA3038-3D34-4DD1-AB27-0058B3BBB1C2Q53811593-7C6E8860-AA4F-431A-B4F4-CE68DA9EAA61
P2860
A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A randomized phase II trial of ...... with metastatic uveal melanoma
@ast
A randomized phase II trial of ...... with metastatic uveal melanoma
@en
A randomized phase II trial of ...... with metastatic uveal melanoma
@nl
type
label
A randomized phase II trial of ...... with metastatic uveal melanoma
@ast
A randomized phase II trial of ...... with metastatic uveal melanoma
@en
A randomized phase II trial of ...... with metastatic uveal melanoma
@nl
prefLabel
A randomized phase II trial of ...... with metastatic uveal melanoma
@ast
A randomized phase II trial of ...... with metastatic uveal melanoma
@en
A randomized phase II trial of ...... with metastatic uveal melanoma
@nl
P2093
P356
P1433
P1476
A randomized phase II trial of ...... with metastatic uveal melanoma
@en
P2093
A Schmittel
M H Foerster
M Schmidt-Hieber
N E Bechrakis
R Schuster
U Keilholz
P304
P356
10.1093/ANNONC/MDL309
P407
P577
2006-12-01T00:00:00Z